MARKET

ICLR

ICLR

ICON PLC
NASDAQ

Real-time Quotes | Nasdaq Last Sale

207.89
-5.20
-2.44%
Closed 16:00 01/27 EST
OPEN
210.92
PREV CLOSE
213.09
HIGH
211.54
LOW
205.56
VOLUME
386.48K
TURNOVER
--
52 WEEK HIGH
223.62
52 WEEK LOW
104.28
MARKET CAP
10.94B
P/E (TTM)
33.79
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Contract Research Organizations (Cros) Services Market Size 2021 By Industry Expansion Strategies, Development Trends, Modest Analysis, Business Prospect, Regional Growth, End User Analysis and Forecast to 2025 Says Industry Research Biz
Jan 27, 2021 (The Expresswire) -- Global “Contract Research Organizations (Cros) Services Market” report is extensive significant analyses of the Contract...
The Express Wire · 1d ago
IQVIA Holdings Inc. stock outperforms competitors despite losses on the day
Shares of IQVIA Holdings Inc. slipped 1.46% to $180.34 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P...
marketwatch.com · 1d ago
IQVIA Holdings Inc. stock falls Monday, underperforms market
Shares of IQVIA Holdings Inc. shed 1.38% to $183.02 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...
marketwatch.com · 2d ago
Life Sciences BPO Market witnessing a CAG R of 8.1% by 2027.
Jan 25, 2021 (Market Insight Reports) -- Nova One Advisor has been monitoring the Life Sciences BPO Market Size and is projected to generate US$ 420.1 Bn by...
Market Insight Reports · 2d ago
Healthcare Contract Research Outsourcing Market Trends and Analysis Research Report 2021 – 2025
Jan 25, 2021 (AmericaNewsHour) -- Global Healthcare Contract Research Outsourcing Market is estimated to reach $58.9 billion by 2025; growing at a CAGR of...
AmericaNewsHour · 3d ago
Contract Research Organizations (CROs) Services Market 2020 Global Industry Trends, Statistics, Size, Share, Regional Analysis by Key Players
Jan 24, 2021 (Heraldkeepers) -- The Global Contract Research Organizations (CROs) Service Market is segmented on the lines of its service type, therapeutic...
Heraldkeepers · 3d ago
IQVIA Holdings Inc. stock underperforms Friday when compared to competitors
Shares of IQVIA Holdings Inc. shed 1.12% to $185.59 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...
marketwatch.com · 5d ago
IQVIA Holdings Inc. stock underperforms Thursday when compared to competitors
Shares of IQVIA Holdings Inc. shed 1.50% to $187.69 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...
marketwatch.com · 6d ago
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ICLR. Analyze the recent business situations of ICON PLC through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 16 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ICLR stock price target is 206.43 with a high estimate of 237.00 and a low estimate of 156.00.
EPS
Institutional Holdings
Institutions: 555
Institutional Holdings: 54.68M
% Owned: 103.90%
Shares Outstanding: 52.63M
TypeInstitutionsShares
Increased
116
1.68M
New
72
66.31K
Decreased
148
1.50M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-3.27%
Pharmaceuticals & Medical Research
-3.25%
Key Executives
Non-Executive Chairman/Director
Ciaran Murray
Chief Executive Officer/Director
Steve Cutler
Chief Financial Officer/IR Contact Officer
Brendan Brennan
Executive Vice President/Chief Administrative Officer/General Counsel/Secretary
Diarmaid Cunningham
Other
Kristen Buck
Lead Director/Independent Director
Ronan Murphy
Independent Director
Hugh Brady
Independent Director
John Climax
Independent Director
Joan Garahy
Independent Director
William Hall
Independent Director
Eugene McCague
Independent Director
Julie O'Neill
Independent Director
Mary Pendergast
  • Dividends
  • Splits
  • Insider Activity
No Data
About ICLR
ICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the clinical development process, from compound selection to Phase I-IV clinical studies. Its services include clinical trials management, biometric activities, consulting, imaging, contract staffing, informatics and laboratory services. The Company's information systems offerings include ICONIK, Firecrest, ADDPLAN, AptivAdvantage and Aptiv Insite. It conducts various laboratory tests on the patient's blood, urine and other bodily fluids at appropriate intervals during the trial. The Company offers clinical development services, including investigator recruitment, patient registries, outcomes research, clinical data management, immunoassay development and others.

Webull offers kinds of ICON PLC stock information, including NASDAQ:ICLR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ICLR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ICLR stock methods without spending real money on the virtual paper trading platform.